4//SEC Filing
Neos Therapeutics, Inc. 4
Accession 0001179110-16-022592
CIK 0001467652operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:53 PM ET
Size
5.2 KB
Accession
0001179110-16-022592
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-04-01+50,000→ 50,000 totalExercise: $10.74Exp: 2026-04-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option vests in 4 equal, annual installments, beginning on April 1, 2017.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001467652
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:53 PM ET
- Size
- 5.2 KB